Nicotine metabolism predicted by CYP2A6 genotypes in relation to smoking cessation: A systematic review.
Stephanie K JonesBethany J WolfBrett FroeligerKristin WallaceMatthew J CarpenterAnthony J AlbergPublished in: Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco (2021)
Most studies included in this review were of European ancestry populations; these showed slower nicotine metabolism was associated with increased likelihood of smoking cessation in a dose-related manner. Pharmacotherapy appeared to attenuate or modify this association among people of European ancestry, but it is unclear whether the change in the association remains consistent after treatment ceases. This finding has implications for precision medicine cessation interventions. Based on only a few studies of people of Asian or African ancestry, the association between CYP2A6 variants and cessation may differ from that observed among those of European ancestry, but more evidence is needed.